References
- Siddiqui, M. R.; AlOthman, Z. A.; Rahman, N. Analytical Techniques in Pharmaceutical Analysis: A Review. Arab. J. Chem. 2017, 10, S1409–S1421. DOI: 10.1016/j.arabjc.2013.04.016.
- Challenges of Analytical Method Transfer in the Pharmaceutical Industry, 2017. http://www.samedanltd.com/uploads/pdf/white_paper/63e82ce24cca8a2bf007e8901c6a55c3.pdf (accessed June 20, 2019).
- ICH Harmonized Tripartite Guideline, Analytical Procedure Development and Revision of Q2 (R1) Analytical Validation, Q14. Final Concept Paper, 2018. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_Q14/Q2R2Q14EWG_ConceptPaper_2018_1115.pdf (accessed June, 20 2019).
- Bhutani, H.; Kurmi, M.; Singh, S.; Beg, S.; Singh, B. Quality by Design (QbD) in Analytical Sciences: An Overview. Pharmatimes 2014, 46, 71–75.
- Panda, S.S., Ed. Analytical QbD Approach for Enhanced Robustness of HPLC Methods; LAP LAMBERT Academic Publishing: Riga, Latvia, 2016.
- Little, T. A. Design of Experiments for Analytical Method Development and Validation, BioPharm., 2014. http://www.biopharminternational.com/design-experiments-analytical-method-development-and-validation?pageID=3 (accessed June 20, 2019).
- Guell, O. A.; Holcombe, J. A. Analytical Applications of Monte Carlo Techniques. Anal. Chem. 1990, 62, 529A–542A. DOI: 10.1021/ac00208a001.
- Monte Carlo simulation, 2019. https://support.minitab.com/en-us/companion/help-and-how-to/tools/monte-carlo-simulation/monte-carlo-simulation/ (accessed June 20, 2019)
- Agrahari, V.; Meng, J.; Zhang, T.; Youan, B.-B. C. Application of Design of Experiment and Simulation Methods to Liquid Chromatography Analysis of Topical HIV Microbicides Stampidine and HI443. J. Anal. Bioanal. Tech. 2014, 5, 1–23. DOI: 10.4172/2155-9872.1000180.
- Beg, S.; Panda, S. S.; Katare, O. P.; Singh, B. Applications of Monte-Carlo Simulation and Chemometric Techniques for Development of Bioanalytical Liquid Chromatography Method for Estimation of Rosuvastatin Calcium. J. Liq. Chromatogr. Relat. Technol. 2017, 40, 907–920. DOI: 10.1080/10826076.2017.1382377.
- Panda, S. S.; Bera, V. V. R. K.; Mohanta, G.; Dash, R.; Patel, P. K. New Stability-Indicating RP-UFLC Method for Determination of Trospium Chloride in Tablet Dosage Form. Sci. Pharm. 2012, 80, 955–964. DOI: 10.3797/scipharm.1207-07.
- Panda, S. S.; Ravi Kumar, B. V. V.; Patel, P. K.; Panda, J. New RP-UFLC Method for Estimation of Xanthinol Nicotinate in Pharmaceutical Dosage Form. Chem. Sci. Trans. 2013, 2, 656–662. DOI: 10.7598/cst2013.379.
- Panda, S. S.; Bera, V. V. R. K.; Dash, R.; Mohanta, G. Determination of Cephalexin Monohydrate in Pharmaceutical Dosage Form by Stability-Indicating RP-UFLC and UV Spectroscopic Methods. Sci. Pharm. 2013, 81, 1029–1041. DOI: 10.3797/scipharm.1306-07.
- Panda, S. S.; Ravi Kumar, B. V. V.; Mohanta, G.; Panda, J. Reverse Phase Ultra Fast Liquid Chromatography Method for Simultaneous Estimation of Citicoline Sodium and Piracetam in Tablets. Int. J. Pharm. Sci. Nanotech. 2013, 6, 1952–1957.
- Panda, S. S.; Ravi Kumar, B. V. V.; Acharjya, S. K.; Sahu, K. RP-UFLC Method for Estimation of Propafenone in Tablets. Int. J. Pharm. Sci. Nanotech. 2014, 7, 2671–2676.
- Pimavanserin Tartarate, 2006–2019. https://pubchem.ncbi.nlm.nih.gov/compound/Pimavanserin-tartrate (accessed June 20, 2019).
- Koduri, G. B.; Bollikolla, H. B.; Dittakavi, R.; Navuluri, S. Quantification of Pimavanserin in Bulk and Tablet Dosage Form Using a Stability Indicating High Performance Liquid Chromatographic Method. Pharm. Sci. 2018, 24, 291–297. DOI: 10.15171/PS.2018.42.
- ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2 (R1). Current Step 4 Version, Parent Guidelines of Methodology, 2005. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf (accessed June 20, 2019).
- Heyden, Y. V.; Jimidar, M.; Hund, E.; Niemeijer, N.; Peeters, R.; Smeyers-Verbeke, J.; Massart, D. L.; Hooghmartens, J. Determination of System Suitability Limits with a Robustness Test. J. Chromatogr. A. 1999, 845, 145–154. DOI: 10.1016/S0021-9673.
- ICH Harmonized Tripartite Guideline, Pharmaceutical Development, Q8 (R2). Current Step 4 Version, Parent Guideline of Pharmaceutical Development, 2009. https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf (accessed June 20, 2019).
- Sahu, P. K.; Ramisetti, N. R.; Cecchi, T.; Swain, S.; Patro, C. S.; Panda, J. An Overview of Experimental Designs in HPLC Method Development and Validation. J. Pharm. Biomed. Anal. 2018, 147, 590–611. DOI: 10.1016/j.jpba.2017.05.006.
- The Impact of pH on HPLC Method Development. http://quimica.udea.edu.co/∼carlopez/cromatogc/ph/95121tb.html (accessed June 20, 2019).